![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](ya6056contents.gif)
Acta Cryst. (2001). E57, o966-o967 [ doi:10.1107/S1600536801015197 ]
Triclinic form of 2-{5,5-dimethyl-3-[2-(2,4,6-trimethoxyphenyl)vinyl]cyclohex-2-enylidene}malononitrile
T. Kolev, Z. Glavcheva, D. Yancheva, M. Schürmann, D.-C. Kleb, H. Preut and P. Bleckmann
Abstract: On slow evaporation of an ethylacetate solution, the title compound, C22H24N2O3, (I), crystallizes in two crystalline forms differing in colour, size and shape. For the structural data on the monoclinic violet form, as well as comment on the differences between the two structures and the details of preparation, see Kolev et al. [Acta Cryst. (2001). E57, o964-o965]. This paper reports the structural results of the red triclinic modification.
Online 29 September 2001
Copyright © International Union of Crystallography
IUCr Webmaster